EUVIMEDEUVIMED entdecken
LeserbriefKommentarOpen Access · CC BY-NC 3.0

Letter to the Editor Regarding "Value of the Platelet-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Product in the Evaluation of Systemic Lupus Erythematosus Disease Activity” [Response to Letter]

Siping Li, Mengxue Yan, Jingyi Lu, Zhichun Liu, Leixi Xue

Journal of Inflammation Research · 2026-10 · Volume 19 · 1-3

DOI: 10.2147/jir.s660588 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Inflammation Research, 2026-10. Verfasst von Siping Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

on our recent article "Value of the Platelet-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Product in the Evaluation of Systemic Lupus Erythematosus Disease Activity".2 We appreciate the opportunity to address the important methodological points raised and fully agree that further validation is necessary, and we believe our response can clarify the rationale and limitations of our study.Dr. Jin correctly notes that the correlation coefficient of PLP with SLEDAI 2000 (ρ = -0.278)does not substantially exceed those of its individual components (platelet count, ρ = -0.180;lymphocyte count, ρ = -0.280).However, we wish to emphasize that the value of PLP is not merely reflected in the magnitude of correlation coefficients but rather in its robustness across different patient subgroups.As shown in our stratified analyses, PLP maintained a significant negative correlation with both SLEDAI 2000 and SLE-DAS in patients with thrombocytopenia (ρ = -0.213and -0.395, respectively), whereas platelet count and lymphocyte count showed weaker or non-significant associations in this subgroup.This suggests that PLP captures the synergistic impact of concurrent cytopenias, which characterize active SLE flares, and may offer a more integrated reflection of systemic immune dysregulation than either parameter alone.Regarding the comparison with other composite indices such as the systemic immune-inflammation index (SII) and systemic inflammation response index (SIRI), we agree that this is an important direction for future research.A recent meta-analysis by Lee and Song demonstrated that SII was significantly correlated with SLEDAI scores (pooled r = 0.322), 3 and Yang et al reported that both SII and SIRI were positively correlated with SLEDAI 2000.4 However, it should be noted that SII and SIRI incorporate neutrophil and monocyte counts in addition to platelet and lymphocyte counts, thereby reflecting a broader spectrum of inflammatory pathways.PLP, in contrast, specifically captures the dual depletion of platelets and lymphocytes that is characteristic of active SLE. 5 The relative performance of these indices deserves head-to-head comparison in future prospective studies.Concerning the potential informational redundancy between platelet-to-lymphocyte ratio (PLR) and PLP, we respectfully disagree that the two indices are merely different transformations of the same biological process.Our data demonstrate a clear differential association pattern: PLR was significantly correlated with disease activity only in patients with normal platelet counts, whereas PLP retained its association regardless of platelet status.This indicates that the two indices capture distinct aspects of the underlying pathophysiology, PLR is confounded by thrombocytopenia, while PLP remains directionally linked to the global cytopenia pattern.Thus, they are complementary rather than redundant, and the choice between them should depend on the clinical context.

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China.

Zitieren

APA

Li, S., Yan, M., Lu, J., Liu, Z., & Xue, L. (2026). Letter to the Editor Regarding "Value of the Platelet-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Product in the Evaluation of Systemic Lupus Erythematosus Disease Activity” [Response to Letter]. Journal of Inflammation Research, Volume 19, 1-3. https://doi.org/10.2147/jir.s660588

Vancouver

Li S, Yan M, Lu J, Liu Z, Xue L. Letter to the Editor Regarding "Value of the Platelet-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Product in the Evaluation of Systemic Lupus Erythematosus Disease Activity” [Response to Letter]. Journal of Inflammation Research. 2026;Volume 19:1-3. doi:10.2147/jir.s660588

BibTeX
@article{Li2026,
  author = {Li, Siping and Yan, Mengxue and Lu, Jingyi and Liu, Zhichun and Xue, Leixi},
  title = {Letter to the Editor Regarding "Value of the Platelet-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Product in the Evaluation of Systemic Lupus Erythematosus Disease Activity” [Response to Letter]},
  journal = {Journal of Inflammation Research},
  year = {2026},
  volume = {Volume 19},
  pages = {1--3},
  doi = {10.2147/jir.s660588}
}
Kostenlos starten →